Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]

View source ↗

Summary

A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer types.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Peritoneal Cancer
• Prostate Cancer

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Ovarian Cancer, Fallopian Tube Cancer | NA | Status: COMPLETED